450
Participants
Start Date
August 15, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
October 31, 2026
SRSD107
SRSD107 is an investigational siRNA product for anticoagulants.
enoxaparin
Enoxaparin is a low molecular weight heparin \[LMWH\] indicated for Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness.
Sirius Therapeutics Co., Ltd.
INDUSTRY